Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Corrias

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Antibiotics and Chemotherapy|January 1, 1996
Vaccination of cynomolgus monkeys with whole inactivated or live-attenuated simian immunodeficiency virusF Titti, L Sernicola, F Corrias, et al.
AIDS (London, England)|March 28, 1998
Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeysS Di Fabio, D Trabattoni, A Geraci, et al.
Journal of Medical Primatology|June 28, 2000
Study of immunological and virological parameters during thalidomide treatment of SIV-infected cynomolgus monkeysS Di Fabio, D Trabattoni, A Geraci, et al.
Virology|April 7, 1999
Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigenL Sernicola, F Corrias, M L Koanga-Mogtomo, et al.
Journal of Medical Primatology|September 14, 2001
Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV(macJ5) on the kinetics of SIV replication in cynomolgus monkeysD R Negri, S Baroncelli, Z Michelini, et al.
The Journal of General Virology|February 12, 1998
Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeysF Titti, L Sernicola, A Geraci, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
In Vivo (Athens, Greece)|May 6, 2009
Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO)F Di Filippo, P Giacomini, C R Rossi, et al.
In Vivo (Athens, Greece)|May 6, 2009
Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusionF Di Filippo, P Giacomini, C R Rossi, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Antibiotics and Chemotherapy|January 1, 1996
Vaccination of cynomolgus monkeys with whole inactivated or live-attenuated simian immunodeficiency virusF Titti, L Sernicola, F Corrias, et al.
AIDS (London, England)|March 28, 1998
Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeysS Di Fabio, D Trabattoni, A Geraci, et al.
Journal of Medical Primatology|June 28, 2000
Study of immunological and virological parameters during thalidomide treatment of SIV-infected cynomolgus monkeysS Di Fabio, D Trabattoni, A Geraci, et al.
Virology|April 7, 1999
Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigenL Sernicola, F Corrias, M L Koanga-Mogtomo, et al.
Journal of Medical Primatology|September 14, 2001
Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV(macJ5) on the kinetics of SIV replication in cynomolgus monkeysD R Negri, S Baroncelli, Z Michelini, et al.
The Journal of General Virology|February 12, 1998
Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeysF Titti, L Sernicola, A Geraci, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
In Vivo (Athens, Greece)|May 6, 2009
Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO)F Di Filippo, P Giacomini, C R Rossi, et al.
In Vivo (Athens, Greece)|May 6, 2009
Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusionF Di Filippo, P Giacomini, C R Rossi, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Pageof 3